Allison C. Hoffman Sells 3,982 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,982 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $105,961.02. Following the transaction, the general counsel now owns 159,137 shares in the company, valued at approximately $4,234,635.57. The trade was a 2.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Phreesia Price Performance

NYSE PHR traded up $1.44 during trading hours on Wednesday, reaching $28.42. 668,317 shares of the company’s stock were exchanged, compared to its average volume of 410,783. The firm has a fifty day moving average of $22.30 and a 200-day moving average of $22.49. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16. The stock has a market cap of $1.65 billion, a PE ratio of -19.33 and a beta of 0.94. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. During the same period last year, the company posted ($0.58) earnings per share. The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. On average, equities research analysts predict that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have commented on PHR shares. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $24.00 to $32.00 in a report on Wednesday. Truist Financial upped their target price on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Robert W. Baird dropped their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Eleven research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $30.64.

Hedge Funds Weigh In On Phreesia

A number of large investors have recently modified their holdings of PHR. Bank of New York Mellon Corp raised its holdings in Phreesia by 8.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock worth $4,546,000 after purchasing an additional 16,614 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Phreesia by 1.0% during the second quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after buying an additional 853 shares during the last quarter. Hsbc Holdings PLC acquired a new position in Phreesia in the second quarter valued at approximately $301,000. Sei Investments Co. boosted its stake in Phreesia by 135.3% in the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after acquiring an additional 95,058 shares during the last quarter. Finally, Ensign Peak Advisors Inc grew its holdings in Phreesia by 3.2% during the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after acquiring an additional 700 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.